These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28588274)

  • 1. Pre- and post-diagnostic β-blocker use and lung cancer survival: A population-based cohort study.
    Weberpals J; Jansen L; Haefeli WE; Hoffmeister M; Wolkewitz M; Herk-Sukel MPPV; Vissers PAJ; Brenner H
    Sci Rep; 2017 Jun; 7(1):2911. PubMed ID: 28588274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immortal time bias in pharmacoepidemiological studies on cancer patient survival: empirical illustration for beta-blocker use in four cancers with different prognosis.
    Weberpals J; Jansen L; van Herk-Sukel MPP; Kuiper JG; Aarts MJ; Vissers PAJ; Brenner H
    Eur J Epidemiol; 2017 Nov; 32(11):1019-1031. PubMed ID: 28864947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.
    Jansen L; Weberpals J; Kuiper JG; Vissers PAJ; Wolkewitz M; Hoffmeister M; Brenner H
    Int J Cancer; 2017 Jul; 141(1):62-71. PubMed ID: 28370155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Blocker use and all-cause mortality of melanoma patients: results from a population-based Dutch cohort study.
    Livingstone E; Hollestein LM; van Herk-Sukel MP; van de Poll-Franse L; Nijsten T; Schadendorf D; de Vries E
    Eur J Cancer; 2013 Dec; 49(18):3863-71. PubMed ID: 23942335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-diagnostic use of beta-blockers and the risk of death in patients with prostate cancer.
    Assayag J; Pollak MN; Azoulay L
    Eur J Cancer; 2014 Nov; 50(16):2838-45. PubMed ID: 25204805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between perioperative beta blocker use and cancer survival following surgical resection.
    Musselman RP; Bennett S; Li W; Mamdani M; Gomes T; van Walraven C; Boushey R; Al-Obeed O; Al-Omran M; Auer RC
    Eur J Surg Oncol; 2018 Aug; 44(8):1164-1169. PubMed ID: 29858097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are comorbidities associated with long-term survival of lung cancer? A population-based cohort study from French cancer registries.
    Seigneurin A; Delafosse P; Trétarre B; Woronoff AS; Velten M; Grosclaude P; Guizard AV; Lapôtre-Ledoux B; Bara S; Molinié F; Colonna M
    BMC Cancer; 2018 Nov; 18(1):1091. PubMed ID: 30419850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-Blocker Use and Lung Cancer Mortality in a Nationwide Cohort Study of Patients with Primary Non-Small Cell Lung Cancer.
    Udumyan R; Montgomery S; Fang F; Valdimarsdottir U; Hardardottir H; Ekbom A; Smedby KE; Fall K
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):119-126. PubMed ID: 31641010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy.
    Grytli HH; Fagerland MW; Fosså SD; Taskén KA; Håheim LL
    Prostate; 2013 Feb; 73(3):250-60. PubMed ID: 22821802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma.
    Udumyan R; Montgomery S; Fang F; Almroth H; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
    Cancer Res; 2017 Jul; 77(13):3700-3707. PubMed ID: 28473530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of ß-blocker use in patients with stable coronary artery disease.
    Bauters C; Lemesle G; Meurice T; Tricot O; de Groote P; Lamblin N
    Heart; 2014 Nov; 100(22):1757-61. PubMed ID: 24947319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Beta-Blocker Dose on Survival After Acute Myocardial Infarction.
    Goldberger JJ; Bonow RO; Cuffe M; Liu L; Rosenberg Y; Shah PK; Smith SC; Subačius H;
    J Am Coll Cardiol; 2015 Sep; 66(13):1431-41. PubMed ID: 26403339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
    Grytli HH; Fagerland MW; Fosså SD; Taskén KA
    Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study.
    Couttenier A; Lacroix O; Silversmit G; Vaes E; De Schutter H; Robert A
    Cancer Epidemiol; 2019 Oct; 62():101579. PubMed ID: 31450179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stage-specific associations between beta blocker use and prognosis after colorectal cancer.
    Jansen L; Hoffmeister M; Arndt V; Chang-Claude J; Brenner H
    Cancer; 2014 Apr; 120(8):1178-86. PubMed ID: 24415516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program.
    Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy CW; Young JB;
    J Am Coll Cardiol; 2008 Jul; 52(3):190-9. PubMed ID: 18617067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pre existing respiratory conditions on survival of lung cancer patients: A nationwide population-based cohort study.
    Hong S; Park EC; Kim TH; Kwon JA; Yoo KB; Han KT; Yoo JW; Kim SJ
    Asia Pac J Clin Oncol; 2018 Apr; 14(2):e71-e80. PubMed ID: 28762660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Yang JH; Hahn JY; Song YB; Choi SH; Choi JH; Lee SH; Kim JH; Ahn YK; Jeong MH; Choi DJ; Park JS; Kim YJ; Park HS; Han KR; Rha SW; Gwon HC
    JACC Cardiovasc Interv; 2014 Jun; 7(6):592-601. PubMed ID: 24947717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
    de Vries F; Souverein PC; Cooper C; Leufkens HG; van Staa TP
    Calcif Tissue Int; 2007 Feb; 80(2):69-75. PubMed ID: 17308987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study.
    Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA
    JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.